当前位置:首页 - 行情中心 - 美康生物(300439) - 财务分析

美康生物

(300439)

  

流通市值:30.14亿  总市值:39.66亿
流通股本:2.92亿   总股本:3.84亿

美康生物(300439)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.30亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益296325.06万元,未分配利润135412.54万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产358794.17万元,负债62469.11万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入374,030,860.651,742,424,499.511,406,709,821.37949,125,024.71
营业总成本350,212,593.711,525,930,374.421,191,514,043.79783,304,290.35
营业利润34,010,148.28267,530,319.93250,212,726.27187,165,359.39
利润总额33,063,815.15282,359,995.47254,980,079.52194,709,245.47
净利润29,779,054.03262,674,724.72223,329,538.72178,325,659.02
其他综合收益-1,157,261.1610,988,800.8-4,248,904.58-5,244,221.58
综合收益总额28,621,792.87273,663,525.52219,080,634.14173,081,437.44
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,721,424,797.371,824,194,344.461,798,075,174.431,811,787,373.19
非流动资产合计1,866,516,898.971,880,920,162.341,765,123,689.861,698,997,919.01
资产总计3,587,941,696.343,705,114,506.83,563,198,864.293,510,785,292.2
流动负债合计522,464,926.94667,437,831.62585,413,207.59594,360,012.08
非流动负债合计102,226,151.51104,208,331.3697,381,710.6385,208,575.21
负债合计624,691,078.45771,646,162.98682,794,918.22679,568,587.29
归属于母公司股东权益合计2,970,496,731.952,939,828,873.182,888,835,756.72,841,098,238.85
股东权益合计2,963,250,617.892,933,468,343.822,880,403,946.072,831,216,704.91
负债和股东权益合计3,587,941,696.343,705,114,506.83,563,198,864.293,510,785,292.2
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计415,715,171.281,990,421,560.11,536,103,915.71,021,509,563.84
经营活动现金流出小计461,974,359.871,592,609,412.451,427,064,292.55921,067,376.15
经营活动产生的现金流量净额-46,259,188.59397,812,147.65109,039,623.15100,442,187.69
投资活动现金流入小计173,477,532.061,012,007,594.1479,909,809.39153,023,384.52
投资活动现金流出小计266,143,555.311,539,117,843.7873,528,042.47412,427,367.54
投资活动产生的现金流量净额-92,666,023.25-527,110,249.6-393,618,233.08-259,403,983.02
筹资活动现金流入小计480,00032,081,058.4131,850,00030,100,000
筹资活动现金流出小计30,289,214.13128,500,100.06109,945,542.21116,871,020.74
筹资活动产生的现金流量净额-29,809,214.13-96,419,041.65-78,095,542.21-86,771,020.74
汇率变动对现金及现金等价物的影响-39,862.028,121.71,154,988.326,774.75
现金及现金等价物净增加额-168,774,287.99-225,709,021.9-361,519,163.82-245,726,041.32
期末现金及现金等价物余额557,840,748.36726,615,036.35590,804,894.43706,598,016.93
TOP↑